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Abstract
Background: In recent years some studies have been published supporting the efficacy of light exposure, physical 
activity, sleep control and a Mediterranean diet pattern on the improvement or prevention of Depression. However, to 
our knowledge, there have been no studies using all these measures together as an adjuvant antidepressant strategy.
Methods: Multicenter, randomized, controlled, two arm-parallel, clinical trial. Eighty depressed patients undergoing 
standard antidepressant treatment will be advised to follow four additional hygienic-dietary recommendations about 
exercise, diet, sunlight exposure and sleep. Outcome measures will be assessed before and after the 6 month 
intervention period.
Discussion: We expect the patients in the active recommendations group to experience a greater improvement in 
their depressive symptoms. If so, this would be a great support for doctors who might systematically recommend 
these simple and costless measures, especially in primary care.
Trial Registration: ISRCTN59506583
Background
Depression has become a serious public health burden,
with high prevalence and morbidity rates [1,2]. The prob-
lem of depression, however, is not only one of health, but
rather of poor work performance, absenteeism, medical
visits, hospitalizations, and other expenses generated by
unresolved depressive symptoms [3].
It is estimated that more than one in five patients do
not respond to the first choice treatment and remain
depressed more than two years later [4]. Furthermore,
only half of those responding to antidepressants achieved
complete remission [5]. It seems reasonable, therefore, to
use any adjuvant therapeutic resource that can add some
antidepressant efficacy without compromising safety and
tolerability of standard treatments. In fact, some simple
interventions based on hygienic and dietary habit
changes, which could be considered almost costless and
devoid of side effects, have been proposed. These poten-
tially anti-depressant measures are summarized below.
Exercise
Studies on the influence of exercise on affective disorders
are methodologically difficult, but it is usually found to
have a positive influence [6]. Furthermore, not only
intense exercise, but regular moderate physical activity
would be sufficient to exert positive antidepressant
effects [7,8]. Some Major Depression Treatment Guide-
lines have even proposed exercise as a possible initial
treatment in mild Depression [9].
Diet
In developed societies there are several lifestyle factors,
including food, which are receiving increased attention as
a key factor in maintaining health. Unfortunately, the
Mediterranean diet pattern, rich in vegetables and fish, is
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being replaced in many countries with a less heart-
healthy diet: saturated fats, refined sugars and precooked
products [10,11]. This unhealthy diet can increase the
risk of an imbalance of omega polyunsaturated fatty acids
and can lead as well to vitamin and mineral deficiencies.
All of these factors can induce to a higher risk of Depres-
sion [12]. This would be consistent with the results of
recent studies in which following a Mediterranean diet or
adding supplements of vitamins or omega acids can have
a positive effect on the prevention and treatment of
Depression [11-14].
Sunlight Exposure
The therapeutic potential of phototherapy has been dis-
cussed in last years, especially in a new subtype of psychi-
atric disorder: Seasonal Affective Disorder [15]. Some
reviews support the use of light both in seasonal and non-
seasonal Depression [16,17]. Exposure to sunlight has
also been recommended as a "natural" light treatment
[18].
Sleep control
Several lines of research have established the relationship
between sleep and mental well-being [19]. Any distur-
bance of a normal sleep pattern is associated with a clear
functional limitation and a reduced quality of life. Sleep
d i s t u r b a n c e s  a r e  c o r e  s y m p t o m s  o f  D e p r e s s i o n  [ 2 0 ] .
Some behavioral techniques have been proposed as use-
ful to improving the quality of sleep of depressive
patients, such as sleep scheduling and sleep restriction,
reducing time in bed, avoiding daytime naps and stimulus
control [21].
This paper aims to describe the design of a study to test
the effectiveness of four hygienic-dietary recommenda-
tions as adjunctive treatment in Depression.
These four measures are: to engage in moderate physi-
cal activity for at least one hour a day, to be exposed to
sunlight for at least two hours daily, to have a good night's
sleep hygiene and to follow a Mediterranean diet pattern.
Methods
Study population
Eighty patients will be recruited, aged 18 or more, suffer-
ing from a Depression episode (Major Depressive Disor-
der, Dysthymic Disorder or Bipolar Disorder type I or II,
depressed phase, according to DSM-IV) [22].
Objectives
The main objective of the study is to test the potential
benefit of giving a written series of structured hygienic-
dietary recommendations to depressed patients. We will
compare this group's response to the four specific recom-
mended measures with a control group in which four
general and nonspecific recommendations will be pro-
posed. The study will last six months. Secondary goals
will be to evaluate which of the various sociodemo-
graphic and clinical characteristics influence the effec-
tiveness of the aforementioned recommendations.
Study Design
This is a multicenter study, which includes the Son
Dureta, Son Llàtzer and Joan March Hospitals, located in
Palma de Mallorca. Eighty outpatients with a depressive
episode will be randomly assigned either to the active
treatment group or control group. All participants will
continue standard antidepressant drug treatment con-
trolled by their reference team.
Inclusion Criteria
1. Male and female patients over 18 years.
2. Patients experiencing a depressive episode according
to DSM-IV diagnostic criteria Major Depressive Disor-
der, Dysthymic Disorder or Bipolar Disorder.
3. Patients receiving antidepressant treatment.
5. Patients who have the ability to communicate in
Spanish and give informed written consent.
6. Women of childbearing age practicing safe contra-
ceptive methods.
Exclusion Criteria
1. Patients suffering from another severe disease that
affects the CNS (cerebral organic pathology) or who have
suffered any serious head injury.
2. Other severe psychiatric illnesses (history of schizo-
phrenia or other psychotic disorders, substance depen-
dence or abuse and eating disorders).
3. Presence of a severe, uncontrolled, or potentially
interfering medical condition.
4. Presence of delusions or hallucinations at the time of
the study.
5. Significant risk of suicide. 6. Pregnancy or lactation.
Diagnostic Tools and Measurements
1. DSM-IV criteria for Major Depressive Disorder. The
4th edition of "Diagnostic and Statistical Manual of Men-
tal Disorders" is a widely use comprehensive classification
of officially recognized psychiatric disorders [22]
2.  The Mini International Neuropsychiatric Interview
(MINI)  is a short diagnostic structured interview
designed to generate 17 DSM-IV or ICD10 axis I diagno-
sis [23].
3.  Sociodemographic and clinical questionnaire
designed specifically for this study. Relevant sociodemo-
graphic information regarding gender, date of birth and
age, marital status, education level and occupational sta-
t u s ,  a s  w e l l  a s  c l i n i c a l  d a t a  r e g a r d i n g  a g e  o f  d i s o r d e r
onset, number of previous episodes and current pharma-
cological treatment (type of agent, mean dose and time of
administration) will be collected.Garcia-Toro et al. BMC Public Health 2010, 10:404
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4. The Beck Depression Inventory (BDI) is a test pre-
sented in multiple choice format which purports to mea-
sure presence and degree of depression. Each of the 21-
items of the BDI attempts to assess a specific symptom or
attitude which appear(s) to be specific to depressed
patients, and which are consistent with descriptions of
the depression contained in the psychiatric literature
[24].
5. The SF-36 is a general measure that is intended to
capture quality of life as well as whether an individual is
healthy or not [25]. The SF-36 is made up of 8 scales.
These cover the ability to function and complete every-
day activities, including physical activities and social
activities. The scales also capture well-being, such as
energy or fatigue and mental health.
6. 17-item Hamilton Depression Rating Scale (HAMD).
This is the most commonly used severity scale in clinical
practice and research with mood disorders [26].
7. The Global Clinical Impression rating scales (GCI)
measures symptom severity, treatment response and effi-
cacy of treatments in patients with mental disorders [27].
Trial Procedures: Consent, Baseline Assessments, Blinding 
and Randomization
Collaborating researchers of the three participating insti-
tutions will identify all those potential patients who
might meet the required criteria. During the recruitment
visit patients will be informed of every detail of the study,
answering all questions and concerns that they might
have regarding their participation. Signed informed con-
sents will then be collected (Table 1). Researchers will
confirm that patients meet the criteria required for entry
into the study using the Structured Interview MINI [23].
The following two questionnaires will later be adminis-
tered: Beck Depression Inventory of 21 items (BDI-21)
[24] and Questionnaire on Health Status (SF- 36) [25].
Finally, an appointment will be arranged within a week.
During this baseline interview, a blind assessor will quan-
tify the affective symptomatology through the Hamilton
17-item scale (HAMD-17) [26] and Clinical Global
Impression scale (CGI). Subjects will then be checked to
ensure that they do not show organic pathology which
might induce symptoms of depression (EKG, BP, HR,
BMI). The following tests will also be administered: blood
count, biochemistry, coagulation studies, thyroid func-
tion tests, serology, levels of vitamins (folic acid and vita-
min B12), and urine test with toxic levels, in addition to a
pregnancy test if appropriate.
Patients will then be randomly assigned to one of two
treatment arms according to sequence of entrance, using
blocks of randomization. Patients assigned to the active
treatment group will receive an envelope containing a
sheet of paper with the four hygienic-dietary recommen-
dations under consideration:
1. Go to bed when sleepy and not before 11 o'clock at
night. Use your bed and bedroom only for sleep and sex
(do not read, watch TV or lie on the bed during the day). If
you do not fall asleep after 15 or 20 minutes get up and
start an activity until you feel sleepy enough to go back to
bed. Get up early, never later than 9 a.m., no matter how
well you have slept the night before. Do not lie down or
take a nap during the day.
2. Walk at least 1 hour a day, at a good pace but without
becoming short of breath or being unable to talk while
walking. If you think you have a medical problem which
makes walking difficult or uncomfortable consult your
doctor. Use appropriate footwear for walking and have a
shower or a bath afterwards.
3. Be exposed to sunlight at least 2 hours per day, taking
precautions to avoid sunburn or sunstroke (sunscreen, hat,
etc.).
4. Try to eat a healthy and balanced diet. Eat at regular
hours without snacking between meals. Avoid especially
sweet or sugary drinks. Eat fish at least three times per
week, plus fruit, cereals, nuts and vegetables daily.
The control group will receive an identical envelope,
but the advice will be to perform the pattern of eating,
sleeping, exercise and exposure to light which they think
will make them feel better:
1. Sleep the hours that you feel your body needs.
2. Adapt the pace of daily physical activity to meet your
needs best.
3. If exposed to sunlight take precautions to avoid sun-
burn or sunstroke (sunscreen, hat, etc.).
4. Try to eat a healthy and balanced diet.
After the 6th month patients will be visited and infor-
mation will be sought about health resource utilization
(hospitalizations, number of visits to the emergency
department...) and work status. There will be a new col-
lection of the same physical parameters, and blood and
urine parameters will be studied. The following tests will
again be collected: BDI-21, and SF-36. The blind rater will
also repeat the questionnaires conducted at the begin-
ning of the study: HAMD-17, and CGI.
Outcome Measures
The primary variable of efficacy of the study will be the
score of HAMD-17 obtained by the blind assessors before
and after treatment. A full response is considered if the
decline in scores on the HAMD-17 is greater than 50%,
and a partial response if the reduction is between 25%
and 50%. We will use BDI-21, filled out by the patient,
and also the self-administered SF-36 and the GCI as sec-
ondary efficacy measures.
Power calculation
To estimate the sample size, HAMD-17 final score was
used. The value expected for control group is 12 (SD: 8)Garcia-Toro et al. BMC Public Health 2010, 10:404
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and the value expected for active treatment group is 8
(SD: 6). An alpha error of 5% is assumed and a beta error
rate of 20% is accepted. The final sample is 34 for both
samples. Expecting a 15-20% loss, the necessary sample
size will be 40 patients in each group, constituting thus a
total sample of 80 patients.
Statistical Analyses
Obtained data will be analyzed with the Statistical Pack-
age for the Social Sciences (SPSS) version 17. There will
be a descriptive analysis of baseline variables by compar-
ing these variables between the groups. We will examine
the outcome variables using the Student t-Fisher as mean
comparison test. We will also use the analysis of variance
(ANOVA) repeated means, the Mann-Whitney for com-
parisons involving ordinal variables and the Chi-square
test for categorical variables. For the multivariate analysis
linear and logistic regression models will be used.
Ethics
The protocol has been approved by the Ethical Board of
the Balearic Islands, Spain (n° IB 733/06 PI).
Discussion
If we assume that the prevalence of depression is increas-
ing in western countries, it is necessary to search for rea-
sons which might explain it [1]. One reason could be the
lifestyle of the population, which we know is changing in
recent decades. A significant proportion of the popula-
tion has reduced their physical activity while following a
Table 1: Study Schedule
WEEK 1/"TRIAGE" WEEK O/BASELINE WEEK 24
Sociodemographic questionnaire X
Clinic questionnaire XX
MINI Interview X
Discussion of the study information leaflet X
Signed Consent Form X
Physical parameters
• BP XX
• HR XX
• BMI XX
EKG X
Blood Test XX
Urine Test XX
Self Administered Test
• BDI-21 X X
• SF-36 X X
Test administered by Blind Raters
• HAMD-17 XX
• GCI XX
Delivery of Hygienic-dietetic recommendations XGarcia-Toro et al. BMC Public Health 2010, 10:404
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less healthy diet [8,11]. In addition, there is a tendency to
sleep fewer hours and be less exposed to sunlight [18,19].
We know that these changes in lifestyle have an impact
on brain physiology that may increase depression vulner-
ability [7,12]. There are also very suggestive evolutionary
explanations in this regard. As a species we have evolved
under the selective pressure of vigorous physical activity,
essential for success in the harvesting, hunting and scav-
enging that allowed our ancestors to survive. This activity
took place outdoors and conditioned our diet and our
way of living. It is therefore possible that changes in life-
style of the population in the developed world are con-
tributing to increase depression vulnerability. This study
is based on this hypothesis.
Sleep control, exercise, diet and sunlight exposure have
been separately recommended by several research groups
as treatment for patients with Depression [28-30]. How-
ever, there is very little research on the usefulness of com-
bining these simple hygienic-dietetic measures. There is
an open study that successfully combines three recom-
mendations (exposure to sunlight, exercise and vitamin
pills) in a sample of women without antidepressant treat-
ment [28]. Other studies associate light therapy and exer-
cise programs in subjects with sub-threshold depressive
symptoms [29]. Finally, another study uses sleep depriva-
tion and light therapy in combination with psychophar-
macology in bipolar patients suffering depressive
symptoms [30]. All of them have reported positive
results. However, to our knowledge there has been no
study that meets all of these recommendations combin-
ing sleep, exercise, diet and sunlight exposure. Our study
meets this challenge in a "real word" design: heteroge-
neous samples of depressed patients, with few exclusion
criteria and in normal clinical practice conditions.
These measures, especially exercise and dietary, may be
useful to prevent or improve many other medical condi-
tions besides Depression. For example, comprehensive
lifestyle changes including a low-fat vegetarian diet and
moderate exercise may be able to induce regression of
even severe coronary atherosclerosis [31]. Asking the
patient to follow the clearly written recommended mea-
sures will require very little time on the part of the doctor.
There will be almost no cost to the patient or the health
system. Adverse effects resulting from these recommen-
dations should be not expected.
Main Strengths and Limitations
This is one of the first studies to evaluate the effectiveness
of a lifestyle change intervention on depressive patients as
carried out by regular staff members from several cen-
ters. Due to the fact that this intervention will be done in
daily practice conditions, conclusions could be general-
ized without reservation. This strengthens considerably
the external validity of the trial. The main limitation
might be found in possible evaluation bias. Blind raters
are informed about the hypotheses of the study. This
might make them aware to which group the patients have
been assigned. An involuntary bias of their rating cannot
then be discarded. However, BDI self administered test
could help us to disregard this possibility.
In conclusion, it is our intention to study the possible
benefits of lifestyle changes for patients suffering from
Depression by using a simple combination of hygienic-
dietary recommendations on a written piece of paper. If
successful, this would be a great support for doctors who
might systematically recommend these simple measures
to patients with such a serious disorder. We believe this
finding could be particularly important for primary care,
where Depressive Disorders are very common, especially
among patients who are more frequent attenders [2,32].
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